J-ALEX: alectinib versus crizotinib in ALK-positive lung cancer. Issue 10089 (1st July 2017)

Record Type:: Journal Article
Title:: J-ALEX: alectinib versus crizotinib in ALK-positive lung cancer. Issue 10089 (1st July 2017)
Main Title:: J-ALEX: alectinib versus crizotinib in ALK-positive lung cancer
Authors:: Gainor, Justin F
Shaw, Alice T
Abstract:
Is Part Of:: Lancet. Volume 390:Issue 10089(2017)
Journal:: Lancet
Issue:: Volume 390:Issue 10089(2017)
Issue Display:: Volume 390, Issue 10089 (2017)
Year:: 2017
Volume:: 390
Issue:: 10089
Issue Sort Value:: 2017-0390-10089-0000
Page Start:: 3
Page End:: 4
Publication Date:: 2017-07-01
Subjects:: Medicine -- Periodicals
Medicine -- Periodicals
Medicine
Medicine
Electronic journals
Periodicals
610.5
Journal URLs:: http://www.thelancet.com/ ↗
http://www.sciencedirect.com/science/journal/01406736 ↗
http://www.elsevier.com/journals ↗
DOI:: 10.1016/S0140-6736(17)31074-7 ↗
Languages:: English
ISSNs:: 0140-6736
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - 5146.000000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:: 1691.xml